In the dynamic field of pharmaceutical research and development (R&D), the availability of versatile and high-quality chemical intermediates is paramount for driving innovation. 4-[(4-Hydroxy-2-pyrimidinyl)amino]benzonitrile, identified by its CAS number 189956-45-4, serves not only as a critical intermediate for established drugs like Rilpivirine but also as a valuable building block in broader drug discovery efforts. For R&D scientists seeking reliable chemical suppliers, understanding its utility is key.

A Versatile Building Block for Drug Discovery

The molecular structure of 4-[(4-Hydroxy-2-pyrimidinyl)amino]benzonitrile—featuring both a pyrimidine ring and a benzonitrile moiety linked by an amine—makes it an attractive starting material or intermediate for synthesizing a diverse array of organic compounds. These structural elements are common in many biologically active molecules, suggesting potential applications beyond its primary use in Rilpivirine synthesis. Pharmaceutical R&D teams can leverage this compound to:

• Synthesize Novel Drug Candidates: The reactive sites on the molecule allow for various chemical modifications, enabling the creation of new chemical entities (NCEs) with potential therapeutic activities across different disease areas.
• Explore Structure-Activity Relationships (SAR): By systematically modifying different parts of the 4-[(4-Hydroxy-2-pyrimidinyl)amino]benzonitrile structure, researchers can investigate how these changes affect biological activity, aiding in the optimization of lead compounds.
• Develop New Synthetic Pathways: Its specific chemical properties can inspire the development of novel or more efficient synthetic routes for complex molecules, potentially reducing costs and environmental impact.

Importance of High Purity in R&D

For pharmaceutical R&D, the purity of chemical inputs is non-negotiable. Impurities in intermediates like 4-[(4-Hydroxy-2-pyrimidinyl)amino]benzonitrile can lead to erroneous experimental results, hinder reaction yields, and complicate purification processes. Therefore, R&D scientists typically require intermediates with proven high purity, often ≥98.0% assay, backed by reliable Certificates of Analysis (COA). Sourcing from reputable manufacturers who specialize in pharmaceutical intermediates ensures that the materials used in R&D are consistent and trustworthy.

Procuring for Research and Development Needs

When purchasing 4-[(4-Hydroxy-2-pyrimidinyl)amino]benzonitrile for R&D purposes, scientists often need smaller quantities, but the requirement for guaranteed quality remains high. Establishing relationships with suppliers who offer both research-grade quantities and can scale up to commercial volumes if a project progresses is a strategic advantage. Contacting chemical manufacturers directly for specific purity requirements and availability is the most effective way to secure this intermediate for your research endeavors. Whether you're confirming a known synthesis or exploring new chemical spaces, reliable access to intermediates like CAS 189956-45-4 is fundamental to successful pharmaceutical R&D.